Zoltan Benyo
Overview
Explore the profile of Zoltan Benyo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
120
Citations
1740
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Malyi A, Bronsert P, Schilling O, Honselmann K, Bolm L, Szanyi S, et al.
HPB (Oxford)
. 2025 Jan;
27(3):393-401.
PMID: 39818518
Background: In pancreatic surgery Postoperative pancreatic fistula (POPF) represents the most dreaded complication, for which pancreatic texture is acknowledged as one of the strongest predictors. No consensual objective reference has...
2.
Fekete M, Lehoczki A, Szappanos A, Toth A, Mahdi M, Sotonyi P, et al.
Geroscience
. 2025 Jan;
47(1):745-779.
PMID: 39777702
Long COVID (also known as post-acute sequelae of SARS-CoV-2 infection [PASC] or post-COVID syndrome) is characterized by persistent symptoms that extend beyond the acute phase of SARS-CoV-2 infection, affecting approximately...
3.
Ungvari A, Gulej R, Patai R, Papp Z, Toth A, Szabo A, et al.
Geroscience
. 2025 Jan;
47(1):301-337.
PMID: 39754010
Aging remains the foremost risk factor for cardiovascular and cerebrovascular diseases, surpassing traditional factors in epidemiological significance. This review elucidates the cellular and molecular mechanisms underlying vascular aging, with an...
4.
Pal E, Ungvari Z, Varbiro S, Bereczki D, Benyo Z
Orv Hetil
. 2024 Dec;
165(50):1958-1968.
PMID: 39674980
No abstract available.
5.
Csipo T, Lipecz A, Mukli P, Peterfi A, Szarvas Z, Ungvari A, et al.
Geroscience
. 2024 Nov;
47(1):1329-1344.
PMID: 39604626
With a growing elderly population in the European Union, age-related diseases associated with unhealthy aging pose increasing public health challenges, including a loss of independence and heightened societal burdens. The...
6.
Major E, Lin K, Lee S, Kaldi K, Gyorffy B, Tigyi G, et al.
Acta Pharmacol Sin
. 2024 Aug;
46(1):222-230.
PMID: 39187677
While immune checkpoint inhibitors (ICIs) are promising in the treatment of metastatic melanoma, about half of patients do not respond well to them. Low levels of human leukocyte antigen-DR (HLA-DR)...
7.
Aloss K, Leroy Viana P, Bokhari S, Giunashvili N, Schvarcz C, Bocsi D, et al.
ACS Pharmacol Transl Sci
. 2024 Aug;
7(8):2496-2506.
PMID: 39144564
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype, with limited treatment options. Modulated electro-hyperthermia (mEHT) is a novel adjuvant cancer therapy that induces selective cancer damage. However,...
8.
Ven K, Besztercei B, Janovicz A, Karsai N, Chun J, Tigyi G, et al.
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 38999980
We have previously reported that, in aortic rings, 18:1 lysophosphatidic acid (LPA) can induce both vasodilation and vasoconstriction depending on the integrity of the endothelium. The predominant molecular species generated...
9.
Benyo Z, Clementi E, Cremers S, David B, Guzik T, Heusch G, et al.
Br J Pharmacol
. 2024 Jun;
181(15):2387-2390.
PMID: 38853481
No abstract available.
10.
Nyul-Toth A, Patai R, Csiszar A, Ungvari A, Gulej R, Mukli P, et al.
Geroscience
. 2024 Jun;
46(6):6511-6536.
PMID: 38831182
Aging plays a pivotal role in the pathogenesis of cerebral small vessel disease (CSVD), contributing to the onset and progression of vascular cognitive impairment and dementia (VCID). In older adults,...